Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The prognostic significance of capsular incision into tumor during radical prostatectomy.

Preston MA, Carrière M, Raju G, Morash C, Doucette S, Gerridzen RG, Bella AJ, Eastham JA, Scardino PT, Cagiannos I.

Eur Urol. 2011 Apr;59(4):613-8. doi: 10.1016/j.eururo.2010.12.005. Epub 2010 Dec 21.

PMID:
21195540
2.

The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.

Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC, Epstein JI.

J Urol. 2007 Oct;178(4 Pt 1):1306-10. Epub 2007 Aug 14.

PMID:
17698141
3.

Adverse prognostic significance of capsular incision with radical retropubic prostatectomy.

Shuford MD, Cookson MS, Chang SS, Shintani AK, Tsiatis A, Smith JA Jr, Shappell SB.

J Urol. 2004 Jul;172(1):119-23.

PMID:
15201750
4.

Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates.

Mandel P, Oh SJ, Hagner C, Tennstedt P, Kriegmair MC, Huland H, Graefen M, Tilki D.

World J Urol. 2016 Nov;34(11):1547-1553. Epub 2016 Mar 22.

PMID:
27003277
5.

Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.

Ferrari MK, McNeal JE, Malhotra SM, Brooks JD.

Urology. 2004 Oct;64(4):749-53.

PMID:
15491714
6.

Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?

Barocas DA, Han M, Epstein JI, Chan DY, Trock BJ, Walsh PC, Partin AW.

Urology. 2001 Nov;58(5):746-51.

PMID:
11711353
7.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
8.

Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.

Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC.

Urology. 2003 Aug;62(2):304-9.

PMID:
12893340
9.

Impact of patient age on biochemical recurrence rates following radical prostatectomy.

Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.

J Urol. 2007 Nov;178(5):1933-7; discussion 1937-8. Epub 2007 Sep 17.

PMID:
17868723
10.

Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.

Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.

J Urol. 2005 Dec;174(6):2181-5.

PMID:
16280760
11.

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.

Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.

Cancer. 2003 Apr 15;97(8):1884-93.

12.

Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

Wheeler TM, Dillioglugil O, Kattan MW, Arakawa A, Soh S, Suyama K, Ohori M, Scardino PT.

Hum Pathol. 1998 Aug;29(8):856-62.

PMID:
9712429
13.

Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions.

Boccon-Gibod L, Ravery V, Vordos D, Toublanc M, Delmas V, Boccon-Gibod L.

J Urol. 1998 Oct;160(4):1383-5.

PMID:
9751359
14.

Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.

Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML.

J Urol. 2007 Oct;178(4 Pt 1):1311-5. Epub 2007 Aug 16.

PMID:
17698095
15.

Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer.

Masieri L, Lanciotti M, Nesi G, Lanzi F, Tosi N, Minervini A, Lapini A, Carini M, Serni S.

Urol Int. 2010;85(4):396-400. doi: 10.1159/000315491. Epub 2010 May 28.

PMID:
20516669
16.

Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.

May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.

J Urol. 2007 Nov;178(5):1957-62; discussion 1962. Epub 2007 Sep 17.

PMID:
17868719
17.

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.

Bettencourt MC, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JW.

J Urol. 1996 Sep;156(3):1064-8.

PMID:
8709308
18.

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy.

Ahove DA, Hoffman KE, Hu JC, Choueiri TK, D'Amico AV, Nguyen PL.

Urology. 2010 Nov;76(5):1201-5. doi: 10.1016/j.urology.2010.03.092. Epub 2010 Aug 14.

PMID:
20709376
19.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.

J Urol. 2003 Feb;169(2):517-23.

PMID:
12544300
20.

Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.

Bauer JJ, Srivastava S, Connelly RR, Sesterhenn IA, Preston DM, McLeod DG, Moul JW.

Urology. 1998 Jun;51(6):970-6.

PMID:
9609635

Supplemental Content

Support Center